Table 1.
Results for the comparison of study endpoints between the two treatment groups
Frovatriptan | Zolmitriptan | p | |
---|---|---|---|
Pain-relief episodes at 2 h | 31 (52) | 26 (53) | NS |
Pain-free episodes at 2 h | 16 (22) | 17 (26) | NS |
Pain-relief episodes at 24 h | 50 (83) | 40 (82) | NS |
Pain-free episodes at 24 h | 54 (74) | 45 (69) | NS |
Recurrent episodes at 24 h | 11 (15) | 14 (22) | <0.05 |
Data are reported as absolute (n) and relative (%) frequency. P refers to the statistical significance of the difference between the two study drugs